Literature DB >> 23983371

Antimicrobial potentials of silver colloidal (nanorods) on clinical isolates in Bayelsa state, Nigeria.

Tatfeng Y Mirabeau1, T O Ojo, Simon M Agwale.   

Abstract

Antimicrobial resistance in developing countries has long been an issue of major concern. Nanotechnology has become an eye opener for the intervention on multiple drug resistance organisms. In this study we investigated the antimicrobial potentials of Silver Nitrate (nanorods) solution used in managing infectious diseases, the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of the product against microbial isolates were determined using standard microbiological techniques. The mean MIC and MBC of silver nitrate solution on fungi (0.16 µg/ml and 0.29 µg/ml respectively) was significantly lower than that of Gram positive organisms (2.35µg/ml and 2.62µg/ml) and Gram negative organisms (2.05 µg/ml and 2.10 µg/ml). Of all the Gram positive organisms, Staphylococcus spp recorded the lowest mean MIC and MBC while in the Gram negative organisms group, E. coli isolates showed the lowest mean MIC and MBC of the silver nitrate solution, though not significantly different from the other isolates. In conclusion, results from this study revealed that Silver Nitrate(nanorods) may have be broad spectrum in activity, but with higher antifungal potentials.

Entities:  

Keywords:  Antimicrobial; Bayelsa; clinical isolates; silver colloidal

Mesh:

Substances:

Year:  2012        PMID: 23983371      PMCID: PMC3746671          DOI: 10.4314/ajtcam.v9i3.13

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  9 in total

Review 1.  Anti-infective efficacy of silver-coated medical prostheses.

Authors:  R O Darouiche
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

2.  TREATMENT OF LARGE HUMAN BURNS WITH 0.5 PER CENT SILVER NITRATE SOLUTION.

Authors:  C A MOYER; L BRENTANO; D L GRAVENS; H W MARGRAF; W W MONAFO
Journal:  Arch Surg       Date:  1965-06

3.  A hexameric transmembrane pore revealed by two-dimensional crystallization of the large mechanosensitive ion channel (MscL) of Escherichia coli.

Authors:  N Saint; J J Lacapère; L Q Gu; A Ghazi; B Martinac; J L Rigaud
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

4.  Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.

Authors:  C L Fox
Journal:  Arch Surg       Date:  1968-02

5.  Antimicrobial effects of silver nanoparticles.

Authors:  Jun Sung Kim; Eunye Kuk; Kyeong Nam Yu; Jong-Ho Kim; Sung Jin Park; Hu Jang Lee; So Hyun Kim; Young Kyung Park; Yong Ho Park; Cheol-Yong Hwang; Yong-Kwon Kim; Yoon-Sik Lee; Dae Hong Jeong; Myung-Haing Cho
Journal:  Nanomedicine       Date:  2007-03       Impact factor: 5.307

Review 6.  Silver in health care: antimicrobial effects and safety in use.

Authors:  Alan B G Lansdown
Journal:  Curr Probl Dermatol       Date:  2006

Review 7.  Silver-containing dressings and the need for evidence.

Authors:  Michel H Hermans
Journal:  Am J Nurs       Date:  2006-12       Impact factor: 2.220

Review 8.  Effect of silver on burn wound infection control and healing: review of the literature.

Authors:  Bishara S Atiyeh; Michel Costagliola; Shady N Hayek; Saad A Dibo
Journal:  Burns       Date:  2006-11-29       Impact factor: 2.744

9.  Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?

Authors:  Franck Furno; Kelly S Morley; Ben Wong; Barry L Sharp; Polly L Arnold; Steven M Howdle; Roger Bayston; Paul D Brown; Peter D Winship; Helen J Reid
Journal:  J Antimicrob Chemother       Date:  2004-11-10       Impact factor: 5.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.